Nathan Rich
Stock Analyst at Goldman Sachs
(1.10)
# 3,420
Out of 4,814 analysts
89
Total ratings
34.92%
Success rate
-10.24%
Average return
Main Sectors:
Stocks Rated by Nathan Rich
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Neutral | $16 → $21 | $12.35 | +70.04% | 6 | May 9, 2024 | |
| ZTS Zoetis | Maintains: Buy | $223 → $196 | $148.66 | +31.84% | 9 | May 6, 2024 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $34 → $30 | $12.84 | +133.64% | 8 | May 6, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6.25 → $8 | $7.36 | +8.70% | 7 | May 6, 2024 | |
| NVST Envista Holdings | Maintains: Sell | $20 → $18 | $15.19 | +15.21% | 4 | May 3, 2024 | |
| HUM Humana | Maintains: Buy | $450 → $385 | $264.38 | +45.63% | 7 | Apr 3, 2024 | |
| ELAN Elanco Animal Health | Maintains: Sell | $13 → $14 | $8.44 | +65.88% | 9 | Feb 27, 2024 | |
| TEVA Teva Pharmaceutical Industries | Maintains: Neutral | $10 → $11 | $13.64 | -19.33% | 4 | Feb 5, 2024 | |
| ALGN Align Technology | Maintains: Sell | $197 → $225 | $171.41 | +31.26% | 2 | Feb 2, 2024 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $500 → $650 | $411.55 | +57.94% | 3 | Jan 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $30 | $31.33 | -4.25% | 5 | Dec 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $88 | $67.28 | +30.80% | 9 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $12 | $19.43 | -38.24% | 6 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $93 → $85 | $64.28 | +32.23% | 1 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $7.39 | +48.85% | 3 | May 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $335 | $322.37 | +3.92% | 1 | Dec 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $535 | $454.11 | +17.81% | 5 | Dec 14, 2021 |
Oscar Health
May 9, 2024
Maintains: Neutral
Price Target: $16 → $21
Current: $12.35
Upside: +70.04%
Zoetis
May 6, 2024
Maintains: Buy
Price Target: $223 → $196
Current: $148.66
Upside: +31.84%
DENTSPLY SIRONA
May 6, 2024
Maintains: Neutral
Price Target: $34 → $30
Current: $12.84
Upside: +133.64%
Amneal Pharmaceuticals
May 6, 2024
Maintains: Buy
Price Target: $6.25 → $8
Current: $7.36
Upside: +8.70%
Envista Holdings
May 3, 2024
Maintains: Sell
Price Target: $20 → $18
Current: $15.19
Upside: +15.21%
Humana
Apr 3, 2024
Maintains: Buy
Price Target: $450 → $385
Current: $264.38
Upside: +45.63%
Elanco Animal Health
Feb 27, 2024
Maintains: Sell
Price Target: $13 → $14
Current: $8.44
Upside: +65.88%
Teva Pharmaceutical Industries
Feb 5, 2024
Maintains: Neutral
Price Target: $10 → $11
Current: $13.64
Upside: -19.33%
Align Technology
Feb 2, 2024
Maintains: Sell
Price Target: $197 → $225
Current: $171.41
Upside: +31.26%
IDEXX Laboratories
Jan 17, 2024
Maintains: Buy
Price Target: $500 → $650
Current: $411.55
Upside: +57.94%
Dec 1, 2023
Maintains: Neutral
Price Target: $35 → $30
Current: $31.33
Upside: -4.25%
May 4, 2023
Maintains: Buy
Price Target: $100 → $88
Current: $67.28
Upside: +30.80%
Apr 19, 2023
Maintains: Buy
Price Target: $14 → $12
Current: $19.43
Upside: -38.24%
Jul 21, 2022
Downgrades: Neutral
Price Target: $93 → $85
Current: $64.28
Upside: +32.23%
May 12, 2022
Maintains: Neutral
Price Target: $10 → $11
Current: $7.39
Upside: +48.85%
Dec 14, 2021
Initiates: Buy
Price Target: $335
Current: $322.37
Upside: +3.92%
Dec 14, 2021
Initiates: Buy
Price Target: $535
Current: $454.11
Upside: +17.81%